Objective: To assess the impact on sexual function attributed to lower urinary tract dysfunction in a female obese population. Design: We performed a case-control study based on the registry of a university hospital obesity unit. A consecutive sample of women with body mass index(BMI) X30 (obese) was randomly matched by age, gender and residential county to control subjects using the computerized Register of the Total Population. Data were collected by a self-reported postal survey including the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12). Results: The questionnaire was completed and returned by 279/446 patients (62%) and 430/892 control subjects (48%). Obese women reported significantly lesser satisfaction with their sexual life, more frequent symptoms of urinary incontinence at intercourse, more often fear of urine leakage at intercourse, a higher tendency toward avoiding intercourse and more frequent feelings of guilt and disgust during intercourse (Po0.001). While considering sexual function in a subset of women with urge or stress urinary incontinence, the overall PISQ-12 scores were significantly lower in obese women compared to their age-matched nonobese controls for both the conditions (Po0.001). In an adjusted multivariate analysis, a BMI 430 was independently associated with a significantly increased risk for sexual dysfunction (odds ratio (OR) 1.8; 95% confidence interval (CI) 1.1-2.9), as were symptoms of urge or stress urinary incontinence (OR, 2.0; 95% CI, 1.3-3.1 and OR, 2.6; 95% CI, 1.7-4.0), respectively. Conclusion: Urge and stress urinary incontinences are more common and have greater impact on sexual function in obese women.
Introduction
Along with substantially increased mortality rates 1 obesity also increases the risk for a number of disorders primarily affecting the quality of life and daily function. 2, 3 Obesity is rapidly becoming a major global health problem 4 with farreaching consequences for individual patients as well as societal health-care costs. It is increasingly accepted that obesity is associated with an increased risk for lower urinary tract dysfunction, 5, 6 and, in particular, stress urinary incontinence. [7] [8] [9] [10] Obesity has also been shown to negatively affect the sexual function 11, 12 and may adversely affect the quality of life. 2, 3, 13 Considering the often significant lifestyle alterations and functional disability reported by women with incontinence disorders, the complex interaction between obesity and other risk factors for sexual disability is poorly understood and insufficiently investigated. 14, 15 Although it has been demonstrated that benign pelvic floor disorders are associated with major quality of life implications 12 , studies on sexual function in women with urinary incontinence and pelvic organ prolapse diverge. Some suggest that sexual function is adversely affected by pelvic floor dysfunction, [16] [17] [18] whereas others advocate the opposite. 19, 20 The aim of this case-control study was to assess the risk of sexual dysfunction in obese women in relation to lower urinary tract symptoms in an obese population sample with a body mass index (BMI) X30 kg/m 2 compared to nonobese women with BMI o30 kg/m 2 .
Objects and methods
We performed a case-control-designed study based on the outpatient registry of the Obesity Unit, Karolinska University Hospital Huddinge, Stockholm, Sweden. A consecutive sample consisting of all female patients referred to the clinic for consultation in between February 2003 and January 2006 was identified from the computerized patient ledger (n ¼ 446). To each patient we randomly selected two female control subjects (n ¼ 892) matched for year and month of birth and residential county, from the computerized Register of the Total Population using the unique national registration number assigned to all Swedish residents. The individually unique national registration number allows unambiguous record linkage across all national registers in Sweden.
The Obesity Unit is a tertiary referral clinic at Karolinska University Hospital, which receives patients aged X18 years, generally with a BMIX35 kg/m 2 . Treatment strategy focuses on long-term cognitive behavioral therapy, physical activity, dietary counseling and antiobesity medical treatment.
Study protocol
A comprehensive survey including a general medical history, obstetrical history, as well as the Urogenital Distress Inventory (UDI), 21 the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12), 17, 22 and the Incontinence Impact Questionnaire (IIQ-7), 23 was sent to all patient and control subjects by ordinary mail. The questionnaire also included questions on obesity history, socioeconomic indices (highest level of education, annual income and employment) and lifestyle factors. Current height, weight and waist circumference for all subjects were obtained through the questionnaire and patients were requested to measure the waist circumference using a centimeter-graded measuring tape. Patients not returning the questionnaire following two reminding letters received a phone call and were offered to answer the questionnaire in a telephonic interview. Controls not returning the questionnaire following two reminders were considered nonresponders.
Statistical analysis and ethical consideration
Statistical analysis was performed using Statistica software (Statistica, Statsoft Inc., Tulsa, OK, USA). A sample size calculation determined that a sample of at least 200 cases (exposed) and 400 controls (unexposed) was necessary to demonstrate a 10% difference in prevalence of stress urinary incontinence symptoms (primary outcome variable) with ao0.05 and b ¼ 0.8. Mann-Whitney U-test was used to compare independent nonparametric ordinal and continuous numerical data between groups. A nonresponse to any question was considered as a blank in the final analyses. Main effect analysis of variance (ANOVA) was performed to assess the interaction of urgency urinary incontinence and stress urinary incontinence on the risk for sexual dysfunction. Multivariate logistic regression analysis was performed to assess the interaction of covariates on the risk for sexual dysfunction. Selection of covariates tried in the multivariate model was based on factors associated with sexual dysfunction and lower urinary tract symptoms in existing literature, including age, BMI, somatic comorbidity, parity, menopause, hormone substitution and depression. Risk was estimated using odds ratios (ORs) with 95% confidence intervals (CIs). A P-value o0.05 was considered significant for all analyses. The study was approved by the Research Ethics Committee at Karolinska Institute.
Results

General results
The questionnaire was completed and returned by 279/446 patients (62%), whereas 153 patients (33%) responded but declined participation and 15 patients (3%) were unavailable to follow-up (address unknown or deceased). Eleven patients were excluded due to pregnancy (n ¼ 7), incomplete information on BMI (n ¼ 3) and chronic cystitis (n ¼ 1), leaving 268 patients eligible for analysis. In the control group 456/892 subjects responded (51%), of which 430 subjects completed the questionnaire (48%). In total, 26 subjects (3%) responded but declined to participate and 10 subjects (1%) were not available to follow-up (address unknown or deceased). In total 18 control subjects were excluded due to pregnancy (n ¼ 7) and incomplete information on BMI (n ¼ 11), leaving 412 controls eligible for analysis. Mean age among nonresponders (42 years ±12 s.d.) did not differ significantly from those that responded (45 years ± 12 s.d.).
Post-obese patients with a BMI o30 kg/m 2 and controls with a BMI X30 kg/m 2 were excluded, leaving 246 obese patients and 379 controls eligible for the final analysis. The study groups were similar in age and every patient had a control within the age range of 1 year. Detailed patient characteristics are presented in Table 1 .
BMI, waist circumference and lifestyle As expected, both BMI and waist circumference were significantly higher in obese women compared to the control group (Po0.001) ( Table 1 ). The overall level of education (Po0.001), annual income (Po0.001) and occupation (P ¼ 0.002) in obese women was significantly lower compared to the control group (Table 1) . Overall medical health status was assessed as the number of self-reported somatic diagnoses per subject. The number of control subjects with at least one somatic diagnosis was significantly lower when compared to women in the obese group (34 and 76%, respectively) (Po0.001) ( Table 1) .
Lower urinary tract symptoms
The proportion of obese women experiencing lower urinary tract symptoms was significantly higher compared to
Sexual function and quality of life in obese women I Melin et al nonobese control subjects; urge urinary incontinence, stress urinary incontinence, bladder emptying difficulties, incomplete bladder emptying and pain at urination, were all significant at Po0.001 ( Table 2 ). The prevalence of lower abdominal pressure, lower abdominal pain, pelvic heaviness, pelvic discomfort and vaginal bulging was also more common in obese women compared to control subjects (Po0.001) ( Table 2 ). Other lifestyle factors and events possibly related to the prevalence and bother of lower urinary track symptoms in obese women such as menopausal status, menopausal age and hormone replacement treatment showed no significant differences between the groups. There were no significant differences between the groups with regard to obstetrical history, including overall parity, number of vaginal and cesarean deliveries, instrumental deliveries and number of children with a birth weight over 4 kg.
Sexual function (PISQ-12)
The PISQ-12 has a range from 0 to 48, with higher scores indicating better sexual function. The overall PISQ-12 scores Sexual function and quality of life in obese women I Melin et al were significantly lower in obese women in comparison to the control group (Po0.001). Obese women reported significant lesser satisfaction with their sexual life, more frequent symptoms of urinary incontinence at intercourse, more often fear of urine leakage at intercourse, a greater tendency toward avoiding intercourse and more frequent feelings of guilt and disgust during intercourse (Po0.001) ( Table 3) . Furthermore, obese women reported significantly less sexual excitement (P ¼ 0.03), as well as more frequent problems associated with their partners having an erection (P ¼ 0.04) and premature ejaculation (P ¼ 0.02) ( Table 3) . Sexual desire, ability to have an orgasm with their partner and feeling pain during intercourse was not significantly different between the groups (Table 3 ). In the obese group, mean PISQ-12 scores were significantly lower in women with urge and stress urinary incontinences compared to women without urge and stress urinary incontinences (Po0.001). Controls with stress or urge urinary incontinence had a lower PISQ-12 score than controls without any of the two conditions; however, the difference was not statistically significant (Figures 1 and 2) . While considering sexual function in a subset of women with urge or stress urinary incontinence, the overall PISQ-12 scores were significantly lower in obese women compared to their age-matched nonobese controls for both the conditions (Po0.001) ( Table 3) .
Social inability (IIQ-7)
Compared to the control subjects, obese women reported a significantly higher degree of quality of life impairments attributed to lower urinary tract symptoms: inability to participate in social activities (P ¼ 0.01), physical recreational activities (Po0.001), inability to travel (Po0.001) and a greater impact on emotional health (Po0.001) as measured by the domains of the incontinence impact questionnaire (IIQ-7) ( Table 4) . Sexual function and quality of life in obese women I Melin et al
Risk factor analysis
The logistic regression model was adjusted for age, BMI, somatic comorbidity, parity, menopause, hormone substitution and depression, by adding them step-by-step to the analysis. A BMI 430 was independently associated with a significantly increased risk for sexual dysfunction (OR, 1.8; 95% CI, 1.1-2.9), as were the symptoms of urge or stress urinary incontinence (OR, 2.0; 95% CI, 1.3-3.1 and OR, 2.6; 95% CI, 1.7-4.0, respectively). None of the other factors remained independently associated with the sexual dysfunction at a significant level.
Discussion
In accordance with previous studies, we found that obese women report less sexual excitement, avoidance of sexual encounters 11 lower sexual activity 24 and less satisfaction with their sexual life. 25 The findings of this case-control study also substantiate the notion that obese women with lower urinary tract dysfunction experience a higher degree of sexual dysfunction attributed to their bladder symptoms when compared to normal weight controls. The high rate of sexual dysfunction attributed to lower urinary tract dysfunction in the obese women of the present study may simply be attributed to the increased prevalence and severity of urinary tract symptoms. However, one should also consider other explanations. Women with severe obesity may, in general, have a negative self-and body image, as well as a lower sense of self-esteem when compared to nonobese women. 11, 24, 26 Thus, the complex interaction between selfperception and self-reported symptoms may inflate the problem of sexual dysfunction attributed to lower urinary tract dysfunction in obese women. Obese women also reported more frequent sexual dysfunction in their spouses with regard to premature ejaculation and erection problems. This may adversely affect sexual function scores in our obese population and to some extent contribute to a lower overall score, when compared to nonobese controls. The increased prevalence of lower urinary tract dysfunction and, in particular, stress urinary incontinence in women with severe obesity concurs with previous reports. 6 Although the precise mechanisms behind the association between body weight and stress incontinence remain undecided, abdominal adiposity gives rise to increased intraabdominal Sexual function and quality of life in obese women I Melin et al pressure 27 and subsequently urethral sphincter closing pressure may be compromised. The increased prevalence and bother of urgency in obese women is not so readily explained and may be associated with hormonal and metabolic factors, increased fluid intake or may be secondary to somatic diseases. It is well documented that obesity increases the risk for medical complications and comorbidity, 28 some of which may influence the sexual function and the lower urinary tract symptoms. 29, 30 Somatic comorbidity was entered into our multivariate analysis but showed no significant association with low PISQ-12 scores. We recognize that assessing the impact of comorbidity on lower urinary tract and sexual function may require sophisticated tools, developed and validated specifically for this purpose. As this was not the primary aim of our investigation, it may be prudent to interpret the lack of association between these factors with caution. It was not possible to obtain hormonal data in this setting, which limits some aspects of interpretation of our study. It is, however, unlikely that there were major differences between the cases and the controls, as this would have caused them to be recognized as endocrine as well as incontinent patients. In concurrence with the previous studies, the impact of lower urinary tract dysfunction on quality of life was substantial regardless of the BMI. 16, 31 However, obese women consistently reported a higher degree of impaired quality of life attributed to incontinence in comparison to nonobese controls. The greatest differences were noticed in the domains of emotional health and feelings of frustration. Again, this suggests that obese women may be particularly vulnerable to disorders that reinforce an already negative self-image and self-perception of social status. Our findings are strengthened by the consecutive sampling of a relatively large and homogenous obese population sample, the random sampling of matched control subjects from the source population from where the cases arose, use of condition-specific validated questionnaires and a satisfactory compliance to follow-up. By matching obese patients and nonobese controls by birth date, an expected effect modification by age on the self-reported prevalence of sexual dysfunction and lower urinary tract symptoms was counteracted. As age characteristics did not differ between subjects not responding and those that did, and as they were randomly selected from the total population, it seems unlikely that nonresponders would share an unknown common factor that at the same time acts as a confounder for sexual dysfunction and urinary incontinence. Thus, the difference in response rates between the groups is unlikely to have affected the results.
Despite the significantly lower PISQ-12 scores in obese women, sexual desire did not differ in comparison to the controls. This finding is corroborated by previous studies 32 and suggests that obesity does not necessarily cause a decrease in sexual lust as might be expected. We acknowledge that the intricate psychological mechanisms and pathways involved in sexual arousal and function are difficult to disentangle using a self-reported questionnaire. Thus, we may have oversimplified the interaction. On the other hand, the short form PISQ-12 is validated versus both the full PISQ-31 questionnaire and more general sexual function scales with good correlation. As such it provides a valuable tool for clinical assessment, as well as a tool for implicating research areas of interest for deeper studies.
In conclusion, urge and stress urinary incontinences are more common and have greater impact on sexual function in obese women compared to nonobese controls. The commonness of sexual dysfunction in women with obesity, and those with lower urinary tract dysfunction in general, substantiates the need of routinely evaluating sexual function. The relationship between obesity and sexual function is poorly understood and further research is needed to fully comprehend the intricate consequences on sexuality caused by the obesity epidemic.
